NasdaqGS - Nasdaq Real Time Price USD

Mesa Laboratories, Inc. (MLAB)

Compare

139.61

+2.45

+(1.79%)

At close: January 17 at 4:00:01 PM EST

139.61

0.00

(0.00%)

After hours: January 17 at 4:02:12 PM EST

MESA LABS DECLARES QUARTERLY DIVIDEND

LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 17, 2025, to shareholders of record at the close of business on February 28, 2025. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life science tools and critical quality co

GlobeNewswire 11 days ago

MLAB
+1.79%
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Potentially Undervalued?

Mesa Laboratories, Inc. ( NASDAQ:MLAB ), might not be a large cap stock, but it led the NASDAQGS gainers with a...

Simply Wall St. 12 days ago

MLAB
+1.79%
3 US Stocks Trading Below Estimated Value

As U.S. markets experience a slight pullback following recent record highs, investors are keenly watching how upcoming inflation data might influence Federal Reserve decisions. Amidst this backdrop, identifying stocks trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market fluctuations and economic indicators.

Simply Wall St. last month

MLAB
+1.79%
SMAR

LPRO
Mesa Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations

Mesa Laboratories ( NASDAQ:MLAB ) Second Quarter 2025 Results Key Financial Results Revenue: US$57.8m (up 8.8% from 2Q...

Simply Wall St. 2 months ago

MLAB
+1.79%
Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of -1.21% and 1.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

MLAB
+1.79%
Mesa Labs: Fiscal Q2 Earnings Snapshot

LAKEWOOD, Colo. AP) — Mesa Laboratories Inc. MLAB) on Thursday reported net income of $3.4 million in its fiscal second quarter.

Associated Press Finance 2 months ago

MLAB
+1.79%
Mesa Labs Announces Second Quarter Results

LAKEWOOD, Colo., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quarter (“2Q25”) ended September 30, 2024 (amounts in thousands). Second quarter FY 2025 compared to second quarter FY 2024: Revenues increased 8.8%Non-GAAP core organic revenues¹ decline was 2.8%Operating income increased 5,947% to $3,508 Non-GAAP adjuste

GlobeNewswire 2 months ago

MLAB
+1.79%
Analysis of Chuck Royce's Recent Transaction in Mesa Laboratories Inc

On September 30, 2024, the investment firm managed by Chuck Royce (Trades, Portfolio) executed a significant transaction involving Mesa Laboratories Inc (NASDAQ:MLAB), a prominent player in the life sciences tools and critical quality control products industry. This move is part of a broader strategy that the firm employs, focusing on value investing and portfolio optimization. Charles M. Royce, a renowned figure in the investment world, has been at the helm of the Royce Pennsylvania Mutual Fund since 1972.

GuruFocus.com 3 months ago

MLAB
+1.79%
Shareholders in Mesa Laboratories (NASDAQ:MLAB) are in the red if they invested three years ago

While not a mind-blowing move, it is good to see that the Mesa Laboratories, Inc. ( NASDAQ:MLAB ) share price has...

Simply Wall St. 3 months ago

MLAB
+1.79%
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 30% Discount?

Key Insights Mesa Laboratories' estimated fair value is US$179 based on 2 Stage Free Cash Flow to Equity Mesa...

Simply Wall St. 4 months ago

MLAB
+1.79%
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks 4 months ago

AXGN

MLAB
+1.79%
Surging Earnings Estimates Signal Upside for Mesa Labs (MLAB) Stock

Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks 4 months ago

MLAB
+1.79%
^GSPC
Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade

Mesa Labs (MLAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks 4 months ago

MLAB
+1.79%
Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance

Conestoga Capital Advisors, an asset management company, released its “Micro-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The second quarter of 2024 may be regarded as a time of moderation. Economic indicators largely reflected slowing growth and easing inflation. The moderation theme also drives equity markets. Large-cap stocks, as measured […]

Insider Monkey 5 months ago

MLAB
+1.79%
^RUT
Mesa Labs: Fiscal Q1 Earnings Snapshot

LAKEWOOD, Colo. AP) — Mesa Laboratories Inc. MLAB) on Monday reported earnings of $3.4 million in its fiscal first quarter.

Associated Press Finance 5 months ago

MLAB
+1.79%
Mesa Labs Announces First Quarter Results

LAKEWOOD, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q25”) ended June 30, 2024 (amounts in thousands). First quarter FY 2025 compared to first quarter FY 2024: Revenues increased 14.9%Non-GAAP core organic revenues1 growth was 3.0%Operating income increased 940%Non-GAAP adjusted operating income ex

GlobeNewswire 5 months ago

MLAB
+1.79%
Andvari Sold One of its Longest Holdings Mesa Laboratories (MLAB) in Q2

Andvari Associates, an investment management firm, released its second quarter 2024 investor letter, a copy of which can be downloaded here. Year to date, the portfolio appreciated 7.7% net of fees while the SPDR S&P 500 ETF rose 15.2%. There are two primary causes of Andvari’s trailing returns: (1) the firm does not hold some of the […]

Insider Monkey 5 months ago

MLAB
+1.79%
What Does Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Share Price Indicate?

Mesa Laboratories, Inc. ( NASDAQ:MLAB ), might not be a large cap stock, but it saw a significant share price rise of...

Simply Wall St. 5 months ago

MLAB
+1.79%
Mesa Laboratories Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Mesa Laboratories ( NASDAQ:MLAB ) Full Year 2024 Results Key Financial Results Revenue: US$216.2m (down 1.3% from FY...

Simply Wall St. 7 months ago

MLAB
+1.79%
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results

LAKEWOOD, Colo., June 05, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q24”) and fiscal year (“FY24”) ended March 31, 2024 (amounts in thousands). Fourth quarter FY24 compared to fourth quarter FY23: Revenues increased 6% and increased 10.2% vs 3Q24Non-GAAP core organic revenues1 decreased 3.5%Operating (loss) was

GlobeNewswire 7 months ago

MLAB
+1.79%

Performance Overview

Return	MLAB	S&P 500
YTD	+5.73%	+1.52%
1-Year	+47.21%	+25.82%
3-Year	-52.20%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Mesa Laboratories, Inc. (MLAB)

MESA LABS DECLARES QUARTERLY DIVIDEND

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Potentially Undervalued?

3 US Stocks Trading Below Estimated Value

Mesa Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations

Mesa Labs (MLAB) Lags Q2 Earnings and Revenue Estimates

Mesa Labs: Fiscal Q2 Earnings Snapshot

Mesa Labs Announces Second Quarter Results

Analysis of Chuck Royce's Recent Transaction in Mesa Laboratories Inc

Shareholders in Mesa Laboratories (NASDAQ:MLAB) are in the red if they invested three years ago

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 30% Discount?

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Surging Earnings Estimates Signal Upside for Mesa Labs (MLAB) Stock

Mesa Labs (MLAB) Moves to Strong Buy: Rationale Behind the Upgrade

Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) Due to Inconsistent Performance

Mesa Labs: Fiscal Q1 Earnings Snapshot

Mesa Labs Announces First Quarter Results

Andvari Sold One of its Longest Holdings Mesa Laboratories (MLAB) in Q2

What Does Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Share Price Indicate?

Mesa Laboratories Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results

Performance Overview